Combination Immunotherapy Improves Survival in Mouse Models of Mesothelioma – Drug Discovery & Development
Drug Discovery & Development |
Combination Immunotherapy Improves Survival in Mouse Models of Mesothelioma
Drug Discovery & Development Combined treatment with two cancer immunotherapy drugs – one a novel immune modulator and one that focuses and activates the antitumor immune response – significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma … |
